11 November 2026About
Market Entry Wire

The daily brief on companies, capital and policy moving into the UK and Europe.

Volare secures €7.1m for factory ramp-up and European expansion

The Finnish insect-protein producer has completed a €15m plant in Pori and secured fresh funding to increase output and prepare further factories.

Tomás Ferreira

By Tomás Ferreira, Europe Correspondent · Berlin
26 October 2026 · Reported from Tech.eu

Insect-rearing trays and processing equipment inside an industrial hall in Pori, Finland, with a worker checking a tray.
Insect-rearing trays and processing equipment inside an industrial hall in Pori, Finland, with a worker checking a tray.

Timeline

  1. 2021 — Volare was founded to commercialise technology originating from research at VTT in Finland.
  2. 2022 — Volare’s protein began appearing in commercial products.
  3. October 2026 — Tech.eu reported completion of Volare 01 and €7.1m in new funding for ramp-up and further factory preparations.

Volare raises €7.1m as Pori factory reaches completion

Finnish insect-protein producer Volare has secured €7.1m to increase production at its first industrial plant and prepare additional factories, Tech.eu reports. The financing was arranged through Springvest, with Maki.vc among the new and returning investors backing the business. It gives Volare fresh capital as the company moves from demonstrating its technology to running a substantially larger manufacturing operation.

The completed factory, named Volare 01, occupies 10,000 square metres in Pori, Finland. According to Tech.eu, its annual production targets are up to 5,000 tonnes of insect protein and 2,000 tonnes of insect oil. Construction met the planned delivery date and stayed within a €15m capital expenditure budget; those figures concern the factory project, rather than the latest funding round.

Volare has already secured buyers for a substantial portion of the plant’s capacity, Tech.eu reports. Its offtake partners include aquaculture feed supplier Skretting and an unnamed major international chemicals company. Skretting began testing Volare’s protein early in their relationship, giving the producer an established commercial connection as it prepares to increase output.

Finnish research meets a difficult protein market

Established in 2021, Volare commercialises technology developed through research at VTT Technical Research Centre of Finland. The business uses black soldier flies to turn residual materials from food manufacturing into protein, oil and fertiliser. Tech.eu reports that this approach uses material already generated by the food industry rather than requiring virgin inputs for production.

The founding team brings together agricultural, engineering and waste-management experience. Chief scientific officer Tuure Parviainen trained as an agronomist, researched biomass at the University of Helsinki and worked in biogas. Chief technology officer Matti Tähtinen worked on energy and circular-economy research at VTT. Chief executive Jarna Hyvönen previously developed services at Finland’s largest waste-management company, including work to cut restaurant food waste, according to Tech.eu.

Volare’s demonstration plant produced commercially for more than four years before being transferred to the Pori site, where it remains in operation. Tech.eu describes the new factory as a 1,000-fold increase in scale using the same underlying process. The smaller operation also gave prospective customers somewhere to inspect production and obtain ingredients for product testing before committing to commercial launches.

Products containing Volare protein have been sold since 2022. Tech.eu identifies dog treats developed with Alvar Pet, insect-based cat food from Vafo Group brand Dagsmark, and rainbow trout feed developed with Alltech Fennoaqua. The ingredient has also been used in organic poultry feed. Volare’s protein meal has digestibility above 90 per cent, according to the report.

The expansion comes after several European insect-protein businesses ran into financial trouble. Tech.eu reports that France’s Ÿnsect entered judicial liquidation in 2025 after raising more than €600m. The French government cited technical problems, delayed construction, spending overruns and commercial difficulties. Denmark’s ENORM, which raised €50m in 2022 for a black soldier fly plant, was declared bankrupt on 30 October 2025 following an unsuccessful restructuring.

A different manufacturing model did not protect Germany’s FarmInsect. The Munich company supplied technology for farmers to rear larvae locally using agricultural waste, but entered insolvency proceedings in 2026 and later stopped operating when no buyer emerged. According to Tech.eu, it had attracted approximately €16.2m in equity and public funding; expensive production, cheaper competing proteins and financing delays contributed to its difficulties.

Demand for alternatives nevertheless has a structural driver: pressure on marine resources. Tech.eu cites the FAO’s 2026 report, which found that 84.5 per cent of assessed marine fish stocks were either at their maximum sustainable fishing level or overfished in 2023. That constraint is relevant to feed manufacturers seeking additional protein supplies without relying on greater fishmeal production.

Hyvönen puts cost control and customer commitment first

Speaking to Tech.eu, Hyvönen argued that failures in insect protein should not automatically be treated as evidence against the entire industry. Her assessment was that companies need several capabilities simultaneously: customers willing to buy, suitable technology, scientific expertise and effective execution. She also pointed to regulation, saying the necessary framework had not been in place before 2017.

For Volare, one practical cost decision was to reuse a former newspaper printing building. The conversion took nine months, and Hyvönen estimated that choosing an existing property avoided at least a year of work compared with new construction. She told Tech.eu that floors originally designed to carry heavy printing equipment were well suited to the company’s machinery.

Hyvönen also linked spending discipline to keeping responsibility for engineering and project management inside Volare rather than hiring external consultants for those roles. Suppliers remained involved, but the company retained control over decisions affecting both construction costs and subsequent operations. She told Tech.eu that this was particularly important when designing a first factory whose operating requirements were still highly specific to the business.

The company’s efficiency claims extend beyond construction. Tech.eu reports that Volare’s model requires between one-quarter and one-tenth of competing producers’ capital expenditure, approximately half their staffing and 30 per cent less energy for final-product processing. The Pori facility was designed for four workers per shift, with automation and established industrial equipment helping a small team cover the site.

Hyvönen described two further technical choices to Tech.eu: Volare has developed a fly strain suited to its particular feed materials, and its production processes use electricity rather than natural gas or other fossil fuels. Its patented technology and proprietary equipment designs include a dry-processing method that she said lowers energy costs while preserving ingredient quality.

A second factory would multiply protein capacity fivefold

Volare’s immediate operational task is commissioning the Pori plant and increasing production towards its intended capacity, according to Tech.eu. Completion of the building therefore does not mean the company is already producing at its annual target. The funding will support that transition alongside preparations for subsequent facilities.

The proposed second factory would have roughly five times Volare 01’s protein production capacity, Tech.eu reports. Hyvönen said the longer-term ambition is to establish further plants across Europe and outside it. The report does not identify the next location or give a construction timetable, leaving the geographical sequence of that expansion unspecified.

Replication is built into the technology: much of Volare’s equipment consists of smaller units that can be added repeatedly as output grows. According to Tech.eu, this has enabled the company to validate individual processes over several years rather than depend on a single leap to a much larger, untested system. For its European manufacturing plans, the approach offers a way to carry proven production methods into additional sites.

Volare does not intend to broaden its work to other insects or alternative protein sources. Hyvönen told Tech.eu that, although further product lines are possible, the small team will remain focused on black soldier flies. That decision keeps the expansion programme centred on one biological platform rather than adding another research and industrialisation challenge.

Frequently asked questions

How much funding has Volare raised for expansion?
Tech.eu reports that Volare secured €7.1m through Springvest from new and existing investors, including Maki.vc. The money supports its first industrial factory’s ramp-up and preparations for additional facilities.
Where is Volare’s insect-protein factory?
Volare 01 is in Pori, Finland. The 10,000-square-metre plant occupies a former newspaper printing building and was completed within a €15m capital expenditure budget, according to Tech.eu.
How much protein can Volare 01 produce?
The factory targets up to 5,000 tonnes of insect protein and 2,000 tonnes of insect oil annually. Tech.eu reports that Volare is focused on commissioning and increasing output, rather than already operating at those levels.
What does Volare use to make insect protein?
Volare uses black soldier flies to convert residual materials from food manufacturing into protein, oil and fertiliser. Its technology originated in research at VTT Technical Research Centre of Finland, Tech.eu reports.
Who buys Volare’s insect protein?
Tech.eu identifies commercial uses involving Alvar Pet, Dagsmark and Alltech Fennoaqua. Volare also has offtake agreements with Skretting and an unnamed major international chemicals company.
Where will Volare expand next?
Volare plans further factories across Europe and beyond, but Tech.eu does not identify the next location or construction timetable. A second factory is planned with roughly five times Volare 01’s protein production capacity.
Is Volare planning to use other insects?
No. Chief executive Jarna Hyvönen told Tech.eu that Volare intends to remain focused on black soldier flies, although additional product lines are possible.

Why this matters

For feed and pet-food companies expanding in Europe, Volare offers a potential regional ingredient source with existing commercial applications and buyers. Its next test is operational: increasing output at Pori before replicating the manufacturing model elsewhere. Tech.eu’s reporting also highlights the demands facing new industrial suppliers, from securing customer commitments to controlling construction and processing costs. The sector’s recent failures make those details important when buyers assess long-term supply partners; funding and factory completion alone do not establish sustained production at competitive cost.

Source

Original reporting by Tech.eu. This report was written independently for Market Entry Wire.

More on Expansion Funding

All Expansion Funding coverage →

More from the wire